5th International BAU Drug Design Congress

NEW DRUG DESIGN AND DISCOVERIES IN ALL ASPECTS

The 5th International BAU Drug Design Congress (International BAU-Drug Design Congress 2017) will be held at the BAU Beşiktaş Campus on 19-21 October 2017. During the three-day congress, scientists will discuss the design and development of next-generation drugs and new approaches to the treatment of diseases.

The 5th International BAU Drug Design Congress, where the current state of drug development studies and all aspects of original drug design will be discussed, will once again host scientists renowned in academia and industry. Over the three days of the congress, the latest practices and new approaches in drug research and development will be addressed, along with new approaches designed and used in the treatment of major diseases.

Assoc. Prof. Dr. Serdar Durdağı, faculty member at the Department of Biophysics of Bahçeşehir University Faculty of Medicine and Chair of the Congress, shared the following information about the main aims and objectives of the 5th International BAU Drug Design Congress:

"As average life expectancy increases worldwide, so does the risk of health problems and diseases in later life. For this reason, interest in innovative and rational drug research and development aimed at new treatment mechanisms and the discovery of new therapies is growing in both academia and industry. Over the past five years of this international congress, the number of papers presented and the number of participants from different countries have steadily increased. In these respects, the congress has quickly become one of the most prestigious congresses in this field worldwide. Original drug design and new treatment mechanisms will be discussed over three days. By offering the opportunity to present seminars on new drug discoveries from different disciplines, the congress also aims to accelerate research in this field by contributing to knowledge and technology transfer through new collaborations.

Another objective of the congress is to contribute to scientific discoveries by discussing the latest innovations, developments, applications and approaches in drug design. Developing university-industry and public-private collaboration in the production and use of knowledge and technology is also among our top priorities. The role of R&D studies aimed at developing advanced technology-based products and production processes in industry, how the outputs of these innovative studies should be commercialized, and increasing the number of patents are among the topics to be discussed during the congress."

The main topics to be highlighted at the congress are as follows:

- Artificial drug molecules and clinically oriented studies

- Rare diseases and drug studies

- Targeted therapies that reduce side effects

- Biomedical applications beyond drugs

- Stem cell studies

- Natural molecules